Citation: Dondorp A, White N, Day N (2006) Authors' Reply: Response to Ian Clark. PLoS Med 3(1): e69. https://doi.org/10.1371/journal.pmed.0030069
Published: January 31, 2006
Copyright: © 2006 Dondorp et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing interests: The authors have declared that no competing interests exist.
We are grateful for Ian Clark's suggestions  in response to our research article . Much remains to be learned about the pathogenesis of cerebral malaria. It is certainly hard to disprove that triggering local immune responses contributes in some way to the pathophysiology of cerebral malaria. Local overproduction of NO, HMGB1, cytokines, or other mediators yet to be discovered could impair neurotransmission. But their roles remain hypothetical, and thus far, none of the proposed hypotheses have passed the stage of showing a correlation between the severity of disease and the proposed mediator. A role in murine malaria pathogenesis cannot be translated directly to human pathophysiology since the basic pathophysiological phenomena are essentially different in these animals. Although the concept of impairment of microcirculation in severe malaria by sequestered parasitized erythrocytes causing local tissue dysoxia, acidosis, and metabolic dysfunction is a simple one, there is considerable evidence that it is correct. Lactate/pyruvate ratios are, in contrast with sepsis, clearly increased in severe malaria, which is compatible with anaerobic glycolysis as a source of lactate production . Of the human malarias, only Plasmodium falciparum sequesters in vital organs, and this is also the species responsible for the vast majority of malaria-related deaths. Autopsy studies of fatal malaria cases show convincing correlations between extent of sequestration in the brain and coma as a presenting symptom . Direct visualisation of the microcirculation in patients with severe malaria shows blockage of capillaries, which become patent after the patient's recovery. Strong support for the central role of parasite sequestration in the pathophysiology of lethal malaria comes from the largest trial ever conducted on severe malaria, which showed that artesunate reduces mortality by 34% compared with quinine . Both artesunate and quinine are very active against sequestered parasites, preventing their development to schizonts, but unlike quinine, artesunate is also active against the younger forms of the parasite, preventing their maturation and sequestration in the microcirculation of vital organs. The greatest mortality benefit in this trial compared with quinine was in patients with high parasitaemias, indicating that prevention of sequestration (rather than prevention of schizont rupture) saved lives.
- 1. Clark I (2006) PfHRP2 measures schizogony, not mechanical blockage. PLoS Med 3: e68.I. ClarkPfHRP2 measures schizogony, not mechanical blockage.PLoS Med20063e68
- 2. Dondorp AM, Desakorn V, Pongtavornpinyo W, Sahassananda D, Silamut K, et al. (2005) Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med 2: e204.AM DondorpV. DesakornW. PongtavornpinyoD. SahassanandaK. SilamutEstimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2.PLoS Med20052e204
- 3. Day NP, Phu NP, Mai NTH, Bethel DB, Chau TT, et al. (2000) Prognostic significance of acidosis in severe malaria. Crit Care Med 28: 1833–1840.NP DayNP PhuNTH MaiDB BethelTT ChauPrognostic significance of acidosis in severe malaria.Crit Care Med20002818331840
- 4. Pongponratn E, Turner GD, Day NP, Phu NH, Simpson JA, et al. (2003) An ultrastructural study of the brain in fatal Plasmodium falciparum malaria. Am J Trop Med Hyg 69: 345–359.E. PongponratnGD TurnerNP DayNH PhuJA SimpsonAn ultrastructural study of the brain in fatal Plasmodium falciparum malaria.Am J Trop Med Hyg200369345359
- 5. The South East Asian Quinine Artesunate Malaria Trial (Seaquamat) Group (2005) Artesunate versus quinine for treatment of severe falciparum malaria: A randomised trial. Lancet 366: 717–725.The South East Asian Quinine Artesunate Malaria Trial (Seaquamat) GroupArtesunate versus quinine for treatment of severe falciparum malaria: A randomised trial.Lancet2005366717725